|
|
|
|
Дата |
|---|
| 17.05.2026 |
| 14.05.2026 |
| 13.05.2026 |
| 12.05.2026 |
| 11.05.2026 |
| 10.05.2026 |
| 07.05.2026 |
| 06.05.2026 |
| 05.05.2026 |
| 04.05.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
91.88
|
88.88
|
91.44
|
89.67
|
|
|
27 368 891.32
|
1 125.00
|
|
|
|
91.89
|
91.10
|
92.10
|
91.88
|
|
|
12 586 885.08
|
653.00
|
|
|
|
89.94
|
89.95
|
92.40
|
91.89
|
|
|
59 494 198.25
|
1 359.00
|
|
|
|
89.49
|
88.90
|
90.00
|
89.94
|
|
|
28 877 339.54
|
960.00
|
|
|
|
89.60
|
88.90
|
90.50
|
89.49
|
|
|
38 122 976.83
|
825.00
|
|
|
|
87.40
|
87.04
|
89.75
|
89.60
|
|
|
43 483 910.01
|
1 174.00
|
|
|
|
86.70
|
86.59
|
88.40
|
87.40
|
|
|
32 082 894.23
|
571.00
|
|
|
|
86.70
|
86.59
|
88.40
|
87.40
|
|
|
32 082 894.23
|
571.00
|
|
|
|
86.00
|
84.92
|
87.90
|
86.70
|
|
|
46 362 510.87
|
866.00
|
|
|
|
85.65
|
84.81
|
86.20
|
86.00
|
|
|
26 713 111.58
|
896.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
